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Bacterial lipopolysaccharides  (LPS)  I stimulate mouse  peritoneal macro- 
phages to  lyse  tumor  target  cells  in  vitro  (1-3).  The mechanisms involved  in  the 
differentiation  of  macrophages into  killer  cells  can  now  be  explored  by  using  the 
model described  in the accompanying paper (3).  In that study, purified  LPS 
extracted from a rough mutant of Salmonella  minnesota  (R595) added to 
confluent  monolayers of  elicited  macrophages stimulated the macrophages to 
lyse  tumor target  cells.  The purpose of  this  paper is  to show that macrophage 
stimulation is a generalized property of LPS and to probe the biochemical 
nature of  the differentiation  signal(s)  delivered  by LPS extracted  from the cell 
walls  of  gram-negative  bacteria. 
The biological  activities  of LPS have been localized  to either  the lipid  A 
moiety or to the polysaccharide portions (Fig. 1) (4).  The lipid  A  moiety 
activates  the  classical  complement cascade (5-7)  and significantly  enhances  the 
kallikrein-initiated  cleavage of  Hageman factor  thereby initiating  the intrinsic 
clotting  sequence (8).  Lipid  A also  stimulates  mitogenesis in B lymphocytes (9, 
10).  The polysaccharide  component is  responsible  for  activation  of  the  properdin 
pathway of complement  (7, 11) and bears the molecule's major antigenic 
determinants (4).  Localization  of  the site  of  the stimulation  signal  on LPS may, 
therefore, provide important insights into the mechanism  of macrophage 
stimulation. 
LPS is well characterized biochemically and can be prepared in highly 
purified  form (4).  Moreover, considerable  structural  variation  can be obtained 
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by the use of mutant strains and by chemical modification of the LPS molecule 
(4).  By  using  these  preparations,  we  show  in  this  paper  that  macrophage 
stimulation is a generalized property of LPS molecules and that the site of the 
stimulation signal on LPS resides in the lipid A  moiety.  In the course of these 
investigations,  it became evident that variations in LPS preparative procedures 
resulted  in the isolation  of a  protein rich component noncovalently  bound to 
LPS, which we have called LAP (lipid A associated protein) although its precise 
biochemical  nature  is,  as yet,  undetermined.  We report here that LAP itself 
delivers a stimulatory signal to differentiate macrophages into killer cells which 
is distinct from that produced by lipid A. 
Materials and Methods 
LPS Preparations.  Eight sources of LPS were used in these experiments (Table I). Escherichia 
coli serotypes 0111:B4 (ATCC 12015), 055:B5 (ATC 12014), 075 (a gift of Dr. G. Schmidt, Max Planck 
Institut fiir Immunologie, Frieburg, West  Germany), and  lyophilized  bacteria of the  rough 
mutant  strain E.  coli  B/r  (donated  by  Dr.  Wolfgang  Bessler  of  Institut Microbiologie  II, 
Universitat Tubingen, Tubingen, W.  Germany) were extracted by one of two procedures;  the 
phenol-water method of Westphal and Jann (12) as modified by Lieve et al. (13) or the butanol- 
water method of Morrison and Lieve (14). Preparations of LPS 0111:B4 chromatographed on 
Sepharese 4B yielded two distinct peaks; fraction 1 consisting of the whole  LPS molecule and 
including approximately 10 "O" antigen polysaccharide subunits and fraction II differing from 
fraction I only by a shortened chain of approximately 2 "O" antigen subunits (Fig. 1). LPS from E. 
coli  K235 prepared by a  phenol water method  (15) was  a  gift  from  Dr.  F.  McIntyre of the 
University of Colorado  Medical  Center,  Denver, Colo. LPS from E.  coli  0113 and its native 
protoplasmic pelysaccharide (NPP) were generously provided by Dr. J. Rudbach of the University 
of Montana. Their preparation has been previously reported (16, 17). LPS from R595  S. minnesota 
(provided by Dr. J. Ryan, National Institutes of Health, Bethesda, Md.), was made by the phenol- 
chloreform-petreleum ether method of Galanos et al.  (18). Serratia  marcescens  LPS lot 612017 
(obtained from Difce Laboratories, Detroit, Mich.), was used ai~r suspending  the lyophilized LPS 
in sterile, isotonic saline. Lipid A was produced by acid hydrolysis of LPS from a phenol extract of 
Salmonella typhirnuriurn  R-602 and from E. coli 0111:B4 by using 1% glacial acetic acid at 100°C 
for 2 h (19). LAP was prepared by phenol extraction ofE. coli 0111:B4 and 055:B5 LPS, previously 
extracted by butanol, and subsequently purified. LAP, which partitions into the phenol phase 
was lyophilized,  resuspended in saline, and dialyzed. Base hydrolysis of LPS from E. coli 0111:B4 
and of LAP was performed with 0.01 N NaOH in 90% ethanol at 37°C for 15 and 30 min (20). After 
neutralization with HC1, the preparations were dialyzed extensively against normal saline by 
using small pero dialysis tubing. 
Polyrnyxin B  Treatment.  Polymyxin  B sulphate obtained from Sigma Chemical Co., St. Louis, 
Mo. was incubated with the different preparations of LPS at the same concentration  for 30 min at 
37°C before addition to macrophage monolayers. Since LPS binds pelymyxin B in a stoichiometric 
manner, these conditions provided mild pelymyxin B excess (21). Control preparations contained 
polymyxin B alone. 
Media  and  Cell  Lines.  Eagle's minimal essential medium (MEM) was  supplemented by 
glutamine (2 mM), sodium pyruvate (1 mM), Hepes buffer (20 raM), sodium bicarbonate (0.14%), 
heat-inactivated (56°C, 30 rain) fetal bovine serum (FBS)  (Flow Laboratories, Inc., Rockville, 
Md.),  penicillin (100,000 U/liter) and streptomycin (100,000 /J4,Jliter) (Grand Island Biological 
Co., Grand Island, N.Y.) for use in tissue culture. 
The DBA/2 mastocytoma cell line P815 was maintained in vitro by repeated passages in Hepes 
MEM supplemented by 10% FBS. 
2 The lipid A from Salmonella  typhimurium  R-60 was prepared while D. C. Morrison was a 
guest in the laboratory of Professor  Otto Lfideritz,  Max Planck Institute for Immunobiologie, 
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Macrophage Monolayers.  C57 BL/6J female mice 8- to 10-wk of age were obtained from The 
Jackson Laboratory,  Bar Harbor,  Maine for use as the source of peritoneal macrophages which 
were  elicited by  injecting thioglycollate intraperitoneally  as  previously described  (3).  Macro- 
phage  monolayers  consisting  of approximately  1  x  106  cells were  made  in  16-ram  diameter 
wells of Linbro plates (Flow Laboratories) as described in the accompanying paper (3). We have 
previously demonstrated that after extensive washing of peritoneal exudate cell (PEC) monolay- 
ers  to  remove nonadherent  cells,  such  adherent  cell  monolayers  comprise  greater  than  95% 
macrophages (3). 
Macrophage  Stimulation  by  LPS  and  LAP  Preparations.  Macrophage  monolayers  were 
incubated for 24 h  in Hepes MEM containing 20% heated FBS and appropriate concentrations of 
LAP or LPS preparations before the addition of slCr-laboled target cells. 
Cytolytic Assay.  The mastocytoma cell line P815 was labeled with Na slCr (sp act 0.16 mCi/ 
mg, New England Nuclear Corp., Boston, Mass.~ as described (3). For control experiments, P815 
cells were cultured in H-MEM containing 10% heat-inactivated FBS and 25 pg/ml of LPS-0113 or 
lipid A. After 24 h the cells were washed by centrifugation at 400 g  and then resuspended in H- 
MEM for labeling by using Na 51Cr. 5 x  104-labeled P815 cells were added to appropriately treated 
macrophage monolayers in Linbro plates and incubated at 37°C in 5% CO2 in humidified air for 
periods of 8-24 h. The culture supernates were then harvested and centrifuged at 400 g  for 10 min 
to  remove  cells  and  debris.  Tubes  containing  aliquots  of supernates  were  counted  in  a  ~- 
scintillation counter (Searle Diagnostics Inc., Subsidiary of G. D. Searle & Co., Des Plaines, Ill). 
Results were calculated as  mean  _+  1 SD of four replicates and  expressed  as  a  percentage  of 
radioactivity specifically released using the following calculation: 
where macrophage control release consisted of monolayers which were not treated with LPS. 
Results 
% specific release =  experimental release -  macrophage control release  100 
total releasable counts -  macrophage control release × 
Macrophage Stimulation  is a  General Property of LPS.  As shown in the 
previous paper, LPS derived from the cell wall of the rough mutant strain S. 
minnesota (R595) stimulates macrophages from a PEC population to lyse tumor 
cells in vitro (3). It was important therefore to establish that this was a general 
property of LPS derived from any gram-negative bacterium and not a property 
peculiar to LPS-R595. 
Macrophages preincubated for 24 h  with LPS from eight different sources 
representing beth  rough  and  smooth strains  and prepared by  a  number of 
extraction procedures lysed tumor target cells in  vitro  (Table I).  Since LPS 
derived from a  wide variety of bacterial strains stimulate peritoneal macro- 
phages to become killer cells, this property appears to be shared by all bacterial 
LPS. 
Control studies similar to those shown for LPS-R595 in the: preceding paper 
(3), demonstrated that LPS,  lipid A,  or LAP preparations did not affect the 
viability of 51Cr-labeled P815 target cells over the 24-h incubation period of the 
cytotoxicity assay. Additional control experiments included the preincubation 
of P815 target cells with LPS-0113 or with lipid A for 24 h before slCr labeling. 
When these treated target cells were added to  macrophage monolayers, no 
target cell  lysis occurred providing further evidence that  LPS  and  lipid  A 
stimulation of macrophages is an active process involving a direct effect of LPS 
on macrophages (3). 
Role of Lipid A  in Macrophage Stimulation.  The lipid A component of LPS 
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TABLE I 
Ability of different LPS Preparations to Stimulate Mdp Cytotylic Effect 
Method of extraction 
Specific 
release at 24 
h* 
E. coli 0111:B4 FI 
E. coli 0111:B4 FII 
E. coli 0111:B4 FI 
E. coli 0111:B4 FII 
E. coli K235 
E. coli 055:B5 
E. coli 0113 
E. coli 075 
E. coli B/r 
S. minnesota R595 
S. marcescens 
Lipid A from S. typhimurium R607 
Lipid A from  E. coli 0111:B4  J 
% 
Phenol-water  59 
Phenol-water  58 
Butanol-water  59 
Butanol-water  64 
Phenol-water  44 
Phenol-water  42 
Phenol-water  67 
Phenol-water  43 
Phenol-water  87 
Phenol-chloroform-petreleum ether  75 
Boivin  44 
Acid hydrolysis of phenol  69 
preparations  75 
* Representative results from at least three separate experiments. 
ceae examined (22, 23) while the core polysaccharide defines the genus and the 
O antigens determine strain specificity (4). Since macrophages were stimulated 
by all the  eight different preparations  of LPS which share  only lipid  A  as  a 
common  component  (Table  I),  these  results  suggest  that  lipid  A  bears  the 
stimulatory signal.  Therefore, lipid A purified from LPS 0111:B4 and R:60 was 
tested for its capacity to stimulate macrophages.  As shown in Table I, purified 
lipid A alone induced the macrophages to become cytolytic confirming that this 
LPS moiety delivers a stimulation signal to macrophages. 
Evidence  that  the Polysaccharide  Moiety  Containing  the  0  Antigens  is  not 
Involved  in  Macrophage  Stimulation.  To  determine  whether  the  lipid  A 
moiety was the only part of the LPS molecule that stimulated macrophages or 
whether  the  polysaccharide  components  were  also  involved,  we  used  three 
approaches.  First,  we compared the stimulatory capacity of LPS preparations 
containing  differing  amounts  of carbohydrate  (Fig.  1).  Although  there  were 
slight quantitative differences in the specific release of radioactivity induced by 
these LPS preparations  when  compared on a  weight basis,  each preparation 
stimulated  significant  cytolysis  with  similar  kinetics  (Fig.  2).  The  second 
approach involved incubating the different LPS preparations  with polymyxin 
B, a  cationic polypeptide which forms a  stable molecular complex with lipid A 
(21). The complexing of polymyxin B to lipid A abolishes many of the biological 
activities of LPS including the mitegenic stimulation of B lymphocytes (24) and 
its  capacity to  initiate  the  classical  complement pathway  (25).  Incubation  of 
phenol extracted LPS fromE, coli 0111:B4 fractions I and II, S. minnesota R595, 
and  lipid  A  with polymyxin B  resulted  in  almost complete disappearance  of 
stimulatory  activity,  demonstrating  that  for these  preparations  of LPS,  the 
signal to stimulate the macrophage is localized entirely to the lipid A moiety. 
Third,  we investigated the role of the  O  antigen  polysaccharide chain  in the 
stimulation or modulation of macrophages by LPS. For this purpose, the E. coli DOE,  YANG~  MORRISON,  BETZ,  AND  HI~.NSON  561 
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Fro. I.  Diagram  illustrating  the three regions of contrasting chemical and biological 
properties in protein-free  bacterial lipopolysaccharides. The O  polysaccharide consists  of 
repeating subunits bearing the antigenic specificity  for  each strain,  the  core polysaccharide 
is  common within each genus of  bacteria and is  linked by a trisaccharide  of  2-keto-3-deoxy- 
octulosonate to the lipid  A  moiety which is structurally identical,  or very similar, in all 
Enterobacteriaciae. 
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FIG. 2.  Kinetics of cytolysis of 5~Cr-labeled P815 mastocytoma  cells by macrophages 
preincubated  with 25 pg/ml of LPS R595 from S. minnesota (O), lipid  A from S. typhosa 
R60 (.), and LPS 0111:B4 fractions  I (A) and II (m) from  E. cell  represented by continuous 
lines.  Inhibition  of  the cytolytic  effect  induced by these LPS preparations by preincubation 
with polymyxin B at 25 ~g/ml is represented by the open symbols joined by interrupted 
lines. 
strain  0113 which produces an excess  of  polysaccharide which is antigenically 
identical to the O  antigen polysaccharide of the complete LPS-0113 was used 
(26). The  effects of several concentrations of complete  LPS  0113  and  its 
polysaccharide NPP on macrophage stimulation are shown in Fig.  3. Although 
as little  as 40 ng/ml of complete LPS was highly active,  NPP  produced no 
discernible lysis  at concentrations up to 25 /~g/ml, demonstrating that the 
polysaccharide portion of 0113 does not induce a cytolytic  capacity in macro- 
phages. 
To determine whether the polysaccharide portion  of  LPS could modulate the 
lipid  A signal  of  complete LPS, macrophage monolayers were preincubated with 
NPP for 1 h  at concentrations from 0.04 to 25  ~g/ml before adding 5  ~g/ml of 
complete LPS 0113.  After  24  h,  labeled  P815  cells were added  as targets.  No 
blocking or modulation of cytolysis was observed (Fig. 4). 
Evidence  for  a  Macrophage  Signal  Distinct  from  Lipid  A  in  some  LPS 
Preparations.  In the course of our studies, it became apparent that polymyxin 
B  did not block the activity of all the LPS extracts examined.  When LPS was 
extracted from E. coli 0111:B4  by a butanol procedure (14),  both fractions I and 562  MACROPHAGE  STIMULATION BY  BACTERIAL  LIPOPOLYSACCHARIDES.  II. 
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FIG.  3.  Dose-response  profile for complete LPS from E. coli 0113 (O, continuous line) and 
native protoplasmic polysaccharide,  NPP  (O,  interrupted  lines).  Stimulation of macro- 
phages assayed by their cytolytic effect on 5:Cr-labeled  P815 mastocytoma cells at 24 h. All 
concentrations of LPS-0113 and NPP were preincubated with macrophages for 24 h before 
adding the target cells. 
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/~g/ml  of complete  LPS  0113 to  monolayers  of  1  x  108 
macrophages preincubated for 30 rain with different concentrations of the NPP from E. coli 
0113 (O, continuous line) assayed by macrophage cytolytic effect on 51Cr-labeled P815 cells. 
Dose-response  profile for NPP (© interrupted line) is shown as a control. 
II fully stimulated macrophages to lyse tumor cells (Fig.  5).  After incubation 
with  polymyxin B,  however,  only the  activity  of fraction  I  of the  butanol 
prepared LPS was blocked but the activity of fraction II was entirely unaffected 
(Fig. 5), suggesting that polymyxin B does not bind to butanol LPS fraction II. 
Moreover, since polymyxin B binds to the lipid A region of the LPS molecule 
(21), these results indicate that fraction II of butanol LPS 0111:B4  stimulates 
macrophages by a mechanism independent of lipid A. 
Recent reports from this (27) and other laboratories (28, 29) have shown that 
LPS extracted using butanol  (14),  or trichloroacetic acid  (TCA)  (30) methods 
consists of a complex of LPS and a protein rich component which is firmly bound 
to the lipid A moiety and variously named simple protein,  (28), LAP (27), and 
endotoxin protein (29). We therefore examined the ability of the isolated protein 
rich component, hereafter referred to as LAP, to stimulate a  lytic capacity in 
macrophages. Preparations of LAP from E. coli 0111:B4 and 055:B5,  in concen- DOE,  YANG,  MORRISON,  BETZ,  AND  HENSON 
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FIG. 5.  Kinetics of  cytolysis  of  51Cr-labeled  P815 cells  by macrophages stimulated with 25 
~g/ml 0111:B4 LPS fractions  I  and II  without (O, continuous line)  and with (©, interrupted 
line)  preincubation of  LPS with polymyxin B at 25 ~g/ml. 
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FIG.  6.  Dose-response  profile for  stimulatory effect  of lipid A  associated protein LAP 
isolated from E.  coli 055:B5 (O,  continuous line) and 0111:B4 (©,  interrupted line) on 
macrophage monolayers assayed by cytolysis of slCr-labeled P815 mastocytoma cells. 
TABLE II 
Effect of Mild Base Hydrolysis of LPS and LAP on their 
Capacity to Stimulate Macrophages 
MoP stimulated by: 
% Specific  release from ~Cr P815 cells 
Base-hydrolysed*  Non base-hydrolyzed 
5 ~g/ml  25 ~g/ml  5 ~g/ml  25/~g/ml 
LPS 0111:B4  45  51  30  54 
LAP  0  0  30  77 
* 15 min at 37°C with 0.01 N NaOH in 90% ethanol. 
trations varying from 0.04 to 50 ~g/ml stimulated macrophage monolayers to 
lyse tumor cells in vitro (Fig. 6) indicating that LAP delivers a signal for macro- 
phage stimulation independent from that delivered by lipid A. 
To  show  that  the  LAP  activity  was  not  due  to  contamination of these 
preparations by lipid A but rather represents a functionally distinct entity, we 
took  advantage  of the  exquisite  sensitivity  of LAP  to  very  mild  alkaline 
hydrolysis  (31). Under  such  conditions,  the  capacity  of LAP  to  stimulate 564  MACROPHAGE  STIMULATION  BY  BACTERIAL  LIPOPOLYSACCHARIDES.  n. 
macrophages was  completely abolished  (Table  II).  By contrast,  phenol LPS 
0111:B4  activity was  undiminished by exposure to  identical base  hydrolysis 
conditions (Table II). These results suggest that there is a distinct macrophage 
stimulation signal delivered by the LAP-LPS complex extracted from gram- 
negative bacterial cell walls. The evidence suggests that this signal is localized 
in LAP and is independent of, and separable from, that delivered by the lipid A 
moiety. 
Discussion 
These studies delineate the relationship between the structural characteris- 
tics of LPS from different sources and their ability to stimulate macrophages to 
lyse tumor target cells in vitro.  Stimulation of macrophages appears to be a 
general property of LPS extracted from gram-negative bacterial cell walls. The 
lipid A  component of LPS, which is structurally identical in nearly all LPS 
derived from many bacterial strains (22, 23), boars the stimulatory signal for 
LPS. The polysaccharide moiety containing the repeating O antigen subunits is 
neither stimulatory itself nor does it block the  activity of complete LPS on 
macrophages. Extraction with butanol (14) or TCA (30) results in preparations 
of LPS complexed to  a  protein-rich component, LAP which alone acts  as  a 
distinct stimulator of macrophages. 
LPS extracted from a  wide variety of gram-negative organisms including 
Escherichia, Salmonella,  and Serratia  stimulate macrophages in vitro.  This 
property is shared by complete LPS and by LPS from rough mutant strains in 
which a  heptose deficiency results in a  truncated LPS molecule consisting of 
lipid A plus the core trisaccharide, 2-keto-3-deoxyoctulosonate but lacking the 
long polysaccharide O  antigen chain  (4). Although the  assay  reported here 
measures a  cytolytic effect on tumor target cells, evidence for a  macrophage 
cytostatic effect induced by LPS from Shigella (32) and of the generation of a 
soluble cytolytic factor by macrophages treated with Salmonella typhosa  LPS 
(2) have been reported. Thus, macrophage stimulation by LPS, apparently the 
consequence of direct  interaction  between  LPS  and  macrophages  (3), is  a 
property common to all LPS tested suggesting that macrophages recognize at 
least one component that is structurally identical in nearly all LPS molecules, 
i.e., lipid A. 
Several experimental approaches were used to confirm the localization of the 
LPS  stimulation signal  to  lipid  A.  First,  isolated  lipid  A  alone  induces  a 
macrophage cytolytic effect.  Second, our results demonstrate that when the 
activity of the lipid A moiety of protein free LPS is blocked by polymyxin B, no 
macrophage stimulation occurs indicating that only the lipid A component is 
involved in macrophage stimulation by LPS. The localization of this property to 
the lipid A moiety adds another to the list of  biological actions of  this component 
of LPS which include binding of Clq  (33), initiation of the classical complement 
cascade  (5-7),  enhancement of the kallekrein-initiated cleavage of Hageman 
factor (factor XII) resulting in activation of the intrinsic clotting sequence (8), 
and delivery of a mitogenic signal to B lymphocytes (9, 10). That LPS or its lipid 
A  moiety directly  stimulates macrophages,  as  shown both here  and in  the 
companion paper (3), suggests that these cells may have a membrane receptor 
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Although the polysaccharide portion of LPS has potent biological properties 
including initiation of the properdin pathway of complement (7,  11), and the 
ability to act as a T lymphocyte  independent immunogen (26), it does not appear 
to play a significant role in macrophage stimulation either as a stimulator of 
macrophages or as a modulator of the LPS effect. When the lipid A moiety of 
LPS is rendered inactive by being complexed to polymyxin B, the LPS molecule 
cannot  stimulate macrophages in  vitro.  Moreover, the polysaocharide NPP, 
although antigenically indistinguishable from the O antigens of LPS 0113, has 
no  stimulatory  activity  for  macrophages  nor  does  it  block  the  activity  of 
complete LPS. 
Although butanol extracted LPS fractions I and II from E. coli 0111:B4 are 
fully active as stimulators of macrophages, only the activity of butanol LPS 
fraction I was blocked by incubation with polymyxin B. By contrast, polymyxin 
B neither bound to butanol LPS fraction II nor did it interfere with the ability of 
this LPS to stimulate macrophages indicating that this LPS fraction produces a 
stimulation signal independent of lipid A. When LAP was isolated by phenol 
extraction of butanol LPS 0111:B4 into the phenol phase, isolated LAP from this 
and other bacterial strains was a potent macrophage stimulator suggesting this 
component contained a separate and functionally distinct stimulation signal for 
macrophages. The LAP preparations used in these studies are heterogeneous as 
judged by SDS-polyacrylamide gel electrophoresis and isopycnic density ultra- 
centrifugation in CsC1 (S. J. Betz, unpublished results). The material responsi- 
ble for LAP-initiated macrophage activation has not as yet been characterized. 
However, several pieces of evidence suggest that such activity is independent of 
the low levels of LPS which may contaminate such preparations. A majority of 
isolated E. coli 0111:B4 LAP bands at an average equilibrium density of 1.33 to 
1.34  g/cm  ~ (31) (isolated  LPS  exhibits  a  significantly higher density under 
identical conditions). This lower density material retains the ability to activate 
macrophage cytolytic capacity after isolation from CsC1 gradients  (data not 
shown).  Furthermore, we have shown that LAP activity is sensitive to mild 
alkaline hydrolysis under conditions which do not affect the ability of LPS to 
stimulate macrophages. Nor is the stimulatory capacity of LAP inhibited by 
polymyxin B.  Finally, both the 0111:B4 and 055:B5 LAP preparations used in 
these studies are mitogenic for C3H/HeJ lymphocytes (31). The E. coli 055:B5 
LAP has also been demonstrated to induce the expression of Ia antigens on bone 
marrow cells from C3H/HeJ mice (34, 35). Preliminary studies with C3H/HeJ 
peritoneal macrophages suggest that these cells are also responsive to LAP but 
do not respond to protein-free LPS. 3 Thus, our evidence strongly suggests that 
two separate constituents of the cell walls of gram-negative bacteria, lipid A 
and LAP, deliver distinct signals to differentiate macrophages into killer cells. 
As well as establishing an in vitro model system allowing the biochemical 
dissection of macrophage stimulation, we believe that the findings reported in 
this and in the previous paper have a wider biological  significance. Since the 
macrophage appears  to  be  the  central effector cell  in  the  lesion  of chronic 
inflammation (36), LPS could potentially initiate or perpetuate chronic inflam- 
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mation  in the intestinal  tract where gram-negative  organisms  commensal  in 
the intestinal lumen, and presumably their breakdown products, gain access to 
the submucosa after a  breach in mucosal integrity.  In addition,  our findings 
reveal that there are at least two structurally distinct constituents of cell walls 
of gram-negative  bacteria  (LPS  and  LAP)  which  can  act  as  stimulators  of 
macrophages.  Their differences in structure,  size,  and solubility may broaden 
the environments in which gram-negative organisms can express their biologi- 
cal  activity  in  vivo.  Moreover,  LPS  has  been  shown  to  boost  the  in  vitro 
cytotoxic capacity of murine macrophages obtained directly from solid tumors 
(37) and to induce regression of solid tumors in mice in vivo (38). Therefore, the 
prospect exists of inducing tumor regression  in humans  by using LAP which 
has less potential  for toxic  side effects than  the  complete LPS molecule,  the 
toxicity of which hampers its use as an inducer of tumor regression. 
Summary 
Stimulation  of macrophages  to  lyse  tumor  cells  is  a  property  common  to 
lipepolysaccharide (LPS) extracted from a variety of smooth and rough bacterial 
strains  by several different preparative  procedures.  The relationship between 
macrophage stimulation and the structural characteristics of LPS is defined. In 
protein-free  LPS,  lipid  A  bears  the  stimulatory  signal  which  results  in  the 
differentiation  of elicited  macrophages  into  killer  cells.  The  polysaccharide 
moiety is neither  stimulatory  itself nor does it block the activity of complete 
LPS on macrophages.  Extraction  of LPS by the butanol or Boivin procedures 
produces preparations in which LPS is complexed through its lipid A moiety to 
a protein rich component, LAP. Isolated LAP delivers a macrophage differentia- 
tion  signal  which  is  independent  of  lipid  A.  The  presence  of  these  two 
structurally  distinct  constituents  in  the  cell  walls  of gram-negative  bacteria 
broadens the biological environments in which they can stimulate macrophages 
in vivo. 
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